里克方案正在广泛探讨抢救治疗的多发性骨髓瘤。
RIC regimens are being extensively explored for salvage therapy of myeloma.
术可安全有效地进行治疗椎体骨折引起的多发性骨髓瘤。
PVP can be safely and effectively performed in patients with vertebral body fractures caused by multiple myeloma.
对16例经骨髓穿刺确诊的多发性骨髓瘤的X线表现进行了分析，讨论了多发性骨髓瘤的早期X线表现和鉴别诊断。
Analyzed are 16 cases of multiple myelomas proved by osteostixis Also discussed are the early X-ray manifestations and differential diagnosis of multiple myeloma.
问：当你最早发现自己出现多发性骨髓瘤症状时，却失望地发现现有研究对如何治疗的决定并无多大帮助。
Q: When you first developed symptoms of multiple myeloma, you were disappointed to find that available research was not very helpful in deciding what to do.
这些研究人员将肽（蛋白质片段）化合物作为研究重点，该化合物为多发性骨髓瘤细胞所独有，对于这种细胞的生存至关重要。
The researchers deployed a combination of peptides—small pieces of protein—that are known to be specific to multiple myeloma cells and are important for their survival.
今年是我患上多发性骨髓瘤的第五个年头，这是一种血癌，我回顾了一下患上此病后的一系列突变的症状、治疗以及副作用。
Now entering my fifth year of living with multiple myeloma, a haematological cancer, I reflect back on a roller-coaster ride of symptoms, treatments and side effects.
Sirtris的首席执行官George Vlasuk在一个电话采访中说并发症对于多发性骨髓瘤很普遍，“可能会也可能不会”是和药物有关。
George Vlasuk, chief executive of Sirtris, said in a phone interview that the complication is common in multiple myeloma patients and "may or may not be related to" the drug.
66名患有多发性骨髓瘤(一种血液系统疾病)的患者参与了此项药物试验，结果所有患者的癌灶都缩减了一半。
In a test of 66 patients with the blood disease multiple myeloma, a full 100 percent of the subjects saw their cancer reduced by half.
MultipleMyeloma研究基金会资助了一家小型生物科技企业的研究，发现了一种很有前途的新药，能够治疗多发性骨髓瘤，一种骨头中原生质细胞的癌症。
Research funded by the multiple myeloma Re — search Foundation at a small biotech led to a promising new drug for multiple myeloma, a cancer of plasma cells in bones.
MultipleMyeloma研究基金会资助了一家小型生物科技企业的研究，发现了一种很有前途的新药，能够治疗多发性骨髓瘤，一种骨头中原生质细胞的癌症。
Research funded by the Multiple MyelomaRe--search Foundation at a small biotech led to a promising new drug formultiple myeloma, a cancer of plasma cells in bones.
目的：探讨多发性骨髓瘤(MM)的主要临床特点以及骨髓细胞形态学在MM诊断中的作用。
Objective To investigate the clinical features in patients with multiple myeloma (MM) and the significance of bone marrow cell morphology in MM diagnosis.
颅骨显示多发性骨髓瘤典型的圆形“打孔样”病损。
The skull demonstrates the characteristic rounded "punched out" lesions of multiple myeloma.
“我们已经知道，在B细胞过度表达或突变的NIK和TRAF3分子是与人类多发性骨髓瘤相关，”麦凯教授说。
"We already know that the over-expression or mutation of molecules known as NIK and TRAF3 in B cells is associated with human multiple myeloma," said Professor Mackay.
还有，当大多数人听到的诊断早幼粒细胞白血病，淋巴瘤或多发性骨髓瘤，他们的反应是惊愕，恐惧和难以置信。
Still, when most people hear a diagnosis of leukemia, lymphoma or myeloma they respond with shock, fear and disbelief.
结论：骨髓浆细胞增殖及尿链蛋白产生可能是多发性骨髓瘤肾脏损害的主要原因。
Conclusion: Proliferation of bone marrow plasmacyte and the quantity or urine Bence-Jones protein are main causes of kidney lesion in multiple myeloma.
中倍镜显示多发性骨髓瘤的浆细胞与正常浆细胞很相似，但分化较差。
At medium power, the plasma cells of multiple myeloma here are very similar to normal plasma cells, but they may also be poorly differentiated.
结果：多发性骨髓瘤最常见的临床表现有全身性疼痛、贫血、出血、肾功能损害、发热、肺部感染和全身乏力等。
Results: Most common symptoms of multiple myeloma consist of whole body ache, anemia, bleeding, the kidney dysfunction, fever, infection of lung and fatigue.
结论博宁是一种安全有效的双膦酸盐制剂，与化疗联合应用可以显著缓解多发性骨髓瘤患者的骨痛。
Conclusion Bonin, as a safe and effective Bisphosphonates preparation, could relieve bone pain in multiple myeloma more effectively when combined with chemotherapy.
该文综述了硼替佐米治疗多发性骨髓瘤的临床应用进展。
Clinical progress on bortezomib in the treatment for multiple myeloma was reviewed.
鉴于这个目的，他通过统计学方法对一群多发性骨髓瘤病人的细胞发生的变化进行了分析。
For this purpose, he has analyzed, by means of statistical methods, the cytogenetic changes in a group of patients with MM.
目的：观察密盖息在治疗多发性骨髓瘤疼痛中的作用和总结护理体会。
Objective: To observe the function and nursing of treating ostealgia induced by multiple myeloma with Micalcic.
从这个病例中得到的教训是，在器官移植后的严重免疫抑制状况下，暂时性血细胞恶液质可以有类似多发性骨髓瘤样的表现。
The lesson to be learned from the present case is that a transient plasma cell dyscrasia may present like multiple myeloma in the setting of heavy immunosuppression after organ transplantation.
目的：研究多发性骨髓瘤（MM）的临床及实验室特征。
Objective: To explore the clinical and laboratory features of multiple myeloma(MM) .
目的观察供体白细胞输注(DL I)治疗急慢性白血病和多发性骨髓瘤的疗效和安全性。
Objective To observe the therapeutic efficacy and safety of donor leukocyte infusion (DLI) in acute, chronic leukemia and multiple myeloma.
方法采用三色免疫荧光直接标记法及多参数流式细胞术分析13例多发性骨髓瘤的免疫表型。
Methods Three-colour direct immunofluorescence staining and multiparameter flow cytometry were used for analysis of 13 samples of immunophenotyping of multiple myeloma patients.
这一发现有助于开发靶向治疗白血病、多发性骨髓瘤以及其他血癌的药物。
Their findings may one day help in the development of targeted therapies for leukemia, multiple myeloma and other cancers of the blood.
孤立性的硬膜浆细胞瘤是不常见的，而多发性骨髓瘤相关的浆细胞瘤相对更常见些。
Plasmacytomas of the dura are uncommon plasma cell tumors that may occur as a solitary neoplasm or, more commonly, in association with multiple myeloma.
孤立性的硬膜浆细胞瘤是不常见的，而多发性骨髓瘤相关的浆细胞瘤相对更常见些。
Plasmacytomas of the dura are uncommon plasma cell tumors that may occur as a solitary neoplasm or, more commonly, in association with multiple myeloma.
应用推荐